Effect of recombinant human hemoglobin on human bone marrow progenitor cells: Protection and reversal of 3′-azido-3′-deoxythymidine-induced toxicity

Toxicology Letters

Volumn 85, Issue 1, 1996, Pages 55-62

  Fowler, David A ^a   Rosenthal, Gary J ^b   Sommadossi, Jean Pierre ^a  

^a University of Alabama at Birmingham   (United States)

^b BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

AZT; Recombinant human hemoglobin; Toxicity

Indexed keywords

HEMOGLOBIN; PROTECTIVE AGENT; RECOMBINANT HEMOGLOBIN; UNCLASSIFIED DRUG; ZIDOVUDINE;

ARTICLE; BLOOD TOXICITY; BONE MARROW CELL; CELL PROLIFERATION; CONTROLLED STUDY; HEMATOPOIESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STEM CELL;

ANTIGENS, CD34; ANTIVIRAL AGENTS; BONE MARROW CELLS; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; ERYTHROID PROGENITOR CELLS; HEMATOPOIETIC STEM CELLS; HEMOGLOBINS; HUMANS; RECOMBINANT PROTEINS; ZIDOVUDINE;

EID: 0029876122     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-4274(96)03640-5     Document Type: Article

References (28)

1. Pluda, J.M., Mitsuya, H. and Yarchoan, R. (1991) Hematologic effects of AIDS therapies. Hematol./Oncol. Asp. HIV Dis. 5, 229-248.
2. Richman, D.D., Fischl, M.A., Grieco, M.H., Gottlieb, M.S., Bolberding, P.A., Laskiz, O.L., Leedom, J.M., Groopmen, J.E., Mildvan, D., Hirsch, M.S., Jackson, G.G., Durack, D.T., Musinoff-Lehrman, S. and the AZT Collaborative Working Group (1987) The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N. Engl. J. Med. 317, 192-197.
3. Baum, R.M. (1993) AIDS: scientific progress, but no cure in sight. C & EN July 5, 20-27.
4. Sommadossi, J.P., Zhou, Z., Carlisle, R., Xie, M.Y., Weidner, D.A. and el Kouni, M.H. (1990) Novel pharmacologic approaches to the treatment of AIDS and potential use of uridine phosphorylase inhibitors. In: R.B. Diasio and J.P. Sommadossi (Eds.), Advances in Chemotherapy of AIDS, Pergamon Press, New York, pp. 63-73.
5. Sommadossi, J.P., Carlisle, R., Schinazi, R.F. and Zhou, Z. (1988) Uridine reverses the toxicity of 3′-azido-3′-deoxythymidine in normal human granulocyte-macrophage progenitor cells in vitro without impairment of antiretroviral activity. Antimicrob. Agents Chemother. 32, 997-1001.
6. Fowler, D.A., Ming, M.Y. and Sommadossi, J.P. (1996) Protection and rescue of 2′,3′-dideoxypyrimidine nucleoside analog toxicity by hemin in human bone marrow progenitor cells. Antimicrob. Agents Chemother. (in press).
7. Amberson, W.R. (1937) Blood substitutes. Biol. Rev. 12, 46-74.
8. Amberson, W.R., Jennings, J.J. and Rhode, C.M. (1949) Clinical experience with hemoglobin-saline solutions. J. Appl. Physiol. 1, 469-489.
9. Brandt, J.L., Frank, R. and Lichman, H.C. (1951) The effects of hemoglobin solutions on renal function in man. Blood 6, 1152-1158.
10. Miller, J.H. and McDonald, R.K. (1951) The effect of hemoglobin on renal function in the human. J. Clin. Invest. 30, 1033-1040.
11. Baker, S.L. and Dobbs, B.C. (1925) Obstruction of renal tubules during excretion of hemoglobin. Br. J. Exp. Pathol. 6, 247.
12. Hoffman, S.J., Looker, D.L., Roehrich, J.M., Cozart, P.E., Durfee, S.L., Tedesco, J.L. and Stetler, G.L. (1990) Expression of fully functional tetrameric human hemoglobin in Escherichia coli. Proc. Natl. Acad. Sci. USA 87, 8521-8525.
13. Looker, D., Abbott-Brown, D., Cozart, P., Durfee, S., Hoffman, S., Mathews, A.J., Miller-Roehrich, J., Shoemaker, S., Trimble, S., Fermi, G., Komiyama, N.H., Nagai, K. and Stetler, G.L. (1992) A human recombinant designed for use as a blood substitute. Nature 356, 258-260.
14. Kaartinen, V. and Mononen, I. (1988) Hemoglobin binding to deglycosylated haptoglobin. Biochim. Biophys. Acta 953, 345-352.
15. Garby, L. and Noyes, W.D. (1959) Studies of hemoglobin metabolism. I. The kinetic properties of the plasma hemoglobin pool in normal man. J. Clin. Invest. 38, 1479-1483.
16. Faraj, A., Fowler, D.A., Bridges, E.G. and Sommadossi, J.P. (1994) Effects of 2′,3′-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis. Antimicrob. Agents Chemother. 38, 924-930.
17. Lansdorp, P.M., Sutherland, H.J. and Eaves, C.J. (1990) Selective expression of CD45 isoforms on functional subpopulations of CD34+ hemopoietic cells from human bone marrow. J. Exp. Med. 172, 363-366.
18. Capizzi, R.L., DeConti, R.C., Marsh, J.C. and Bertino, J.R. (1970) Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin 'rescue'. Cancer Res. 30, 1782-1788.
19. Flexner, C., van der Horst, C., Jacobson, M.A., Powderly, W. and Polsky, B. (1994) Relationship between plasma concentrations of 3′-deoxy-3′-flurothymidine (Alovudine) and antiretroviral activity in two concentration-controlled trials. J. Infect. Dis. 170, 1394-1403.
20. Winslow, R.M. (1992) Clinical trials. In: R.M. Winslow (Ed.), Hemoglobin-based Red Cell Substitutes. The Johns Hopkins University Press, Baltimore, MD, p. 199.
21. Rabiner, S.F., Helbert, J.R. and Lopas, H. (1967) Evaluation of stroma-free hemoglobin solution for use as a plasma expander. J. Exp. Med. 126, 1127-1142.
22. Savitzky, J.P., Doczi, J. and Black, J. (1978) A clinical safety trial of stroma-free hemoglobin. Clin. Pharmacol. Ther. 23, 73-80.
23. Shoemaker, S.A., Gerber, M.J., Evans, G.L., Archer-Paik, L.E. and Scoggin, C.H. (1994) Initial clinical experience with a rationally designed, genetically engineered recombinant human hemoglobin. Art. Cells Blood Subs. Immob. Biotech. 22, 457-465.
24. Kumar, R. (1995) Recombinant hemoglobins as blood substitutes: a biotechnology perspective. Soc. Exp. Biol. Med. 208, 150-158.
25. Ogden, J.E. (1992) Recombinant haemoglobin in the development of red-blood-cell substitutes. Trends Biotechnol. 10, 91-96.
26. DeVenuto, F., Friedman, H.I., Neville, J.R. and Peck, C.C. (1979) Appraisal of hemoglobin solution as a blood substitute. Surg. Gynecol. Obstet. 149, 417-436.
27. Monette, F.C. and Holden, A.S. (1982) Hemin enhances the in vitro growth of primitive erythroid progenitor cells. Blood 60, 527-530.
28. Monette, F.C., Holden, S.A., Sheehy, M.J. and Matzinger, E.A. (1984) Specificity of hemin action in vivo at early stages of hematopoietic cell differentiation. Exp. Hematol. 12, 782-787.